"New Clinical Trial Programme for AIDS in the United States"

Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

"New Clinical Trial Programme for AIDS in the United States"

Nature (12/22-29/88) Vol. 336, No. 6201, P. 702
Ezzell, Carol

Under the new community-based clinical trial program announced by the National Institute of Allergy and Infectious Diseases (NIAID) last month, community physicians and clinics will systematically monitor their AIDS patients who receive experimental therapies and report the results to NIAID. The agency hopes this program will get new drugs to minorities and intravenous drug users, who are underrepresented in most clinical trials. NIAID also hopes the program will encourage greater compliance with clinical trial rules. Trial results are often confounded by patients who supplement treatments with black market drugs. Lawrence Deyton of NIAID says he will take steps to insure that true community groups are funded under the program. NIAID Director Anthony Fauci says the AIDS treatment problems point up the basic faults in the U.S. health care system. He also says he will try to focus discussion on how to equip the U.S. Public Health Service to better deal with AIDS.
881222
AD880003

Copyright © 1988 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.